☆ 4.4 Editorial Material

The metabolic axis of ALS: The role of body weight in disease pathogenesis

MUSCLE & NERVE (2023)

Related references

Note: Only part of the references are listed.

Article Clinical Neurology

Body mass index associates with amyotrophic lateral sclerosis survival and metabolomic profiles

Stephen A. Goutman et al.

Summary: This study found that ALS participants experienced weight loss in the 5 years before enrollment, and long-term decrease in BMI was associated with lower survival rates. Metabolomic profiles were also found to be associated with BMI trajectories. Replicating these findings in other cohorts is necessary.

MUSCLE & NERVE (2023)

Add to Collection

Article Clinical Neurology

Metabolomics identifies shared lipid pathways in independent amyotrophic lateral sclerosis cohorts

Stephen A. Goutman et al.

Summary: By performing untargeted metabolomics in two independent ALS cohorts, this study identifies recurring pathways that are altered in both cohorts. Many of the pathways are involved in lipid metabolism, including beta-oxidation intermediates and complex and signalling lipids, such as sphingolipids and diacylglycerols.

BRAIN (2022)

Add to Collection

Article Genetics & Heredity

Clinical and Metabolic Signature of UNC13A rs12608932 Variant in Amyotrophic Lateral Sclerosis

Andrea Calvo et al.

Summary: Patients with amyotrophic lateral sclerosis (ALS) carrying the rs12608932 variant of the UNC13A gene exhibit a specific clinical and cognitive behavioral phenotype, as well as distinct brain F-18-2-fluoro-2-deoxyD-glucose-PET (F-18-FDG-PET) metabolism patterns. The rs12608932 variant should be included in ALS genetic testing to improve prognostic prediction and reduce heterogeneity in clinical trials.

NEUROLOGY-GENETICS (2022)

Add to Collection

Article Clinical Neurology

Associations between lifestyle and amyotrophic lateral sclerosis stratified by C9orf72 genotype: a longitudinal, population-based, case-control study

Henk-Jan Westeneng et al.

Summary: The study found that there are lifestyle differences between patients with ALS and controls decades before onset, depending on C9- status, and these differences are likely part of the presymptomatic causal cascade. Identifying modifiable disease-causing lifestyle factors offers opportunities to lower the risk of developing neurodegenerative disease.

LANCET NEUROLOGY (2021)

Add to Collection

Review Cell Biology

Sphingolipids metabolism alteration in the central nervous system: Amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases

Alexandra Bouscary et al.

Summary: Sphingolipids play crucial roles in the development and maintenance of the nervous system, with dysregulated metabolism being linked to specific neurodegenerative diseases. Current research primarily focuses on ALS, seeking potential treatments that target sphingolipid metabolism in neurodegenerative diseases.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2021)

Add to Collection

Article Clinical Neurology

Effect of High-Caloric Nutrition on Survival in Amyotrophic Lateral Sclerosis

Albert C. Ludolph et al.

ANNALS OF NEUROLOGY (2020)

Add to Collection

Article Clinical Neurology

Life Course Adiposity and Amyotrophic Lateral Sclerosis: A Mendelian Randomization Study

Linjing Zhang et al.

ANNALS OF NEUROLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Skeletal-Muscle Metabolic Reprogramming in ALS-SOD1G93A Mice Predates Disease Onset and Is A Promising Therapeutic Target

Silvia Scaricamazza et al.

ISCIENCE (2020)

Add to Collection

Article Pharmacology & Pharmacy

Ambroxol Hydrochloride Improves Motor Functions and Extends Survival in a Mouse Model of Familial Amyotrophic Lateral Sclerosis

Alexandra Bouscary et al.

FRONTIERS IN PHARMACOLOGY (2019)

Add to Collection

Article Clinical Neurology

Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort

Cristina Moglia et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)

Add to Collection

Article Biotechnology & Applied Microbiology

A Stem Cell-Based Screening Platform Identifies Compounds that Desensitize Motor Neurons to Endoplasmic Reticulum Stress

Sebastian Thams et al.

MOLECULAR THERAPY (2019)

Add to Collection

Article Clinical Neurology

Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis

Martin Gorges et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)

Add to Collection

Article Clinical Neurology

Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis

Pauline Vercruysse et al.

BRAIN (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthase

Alexandre Henriques et al.

HUMAN MOLECULAR GENETICS (2015)

Add to Collection

Article Clinical Neurology

Hypermetabolism in ALS patients: an early and persistent phenomenon

C. Bouteloup et al.

JOURNAL OF NEUROLOGY (2009)

Add to Collection

Article Multidisciplinary Sciences

Evidence for defective energy homeostasis in amyotrophic lateral sclerosis:: benefit of a high-energy diet in a transgenic mouse

L Dupuis et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Add to Collection

Article Clinical Neurology

Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis

RG Cutler et al.

ANNALS OF NEUROLOGY (2002)

Add to Collection

Article Clinical Neurology

Premorbid weight, body mass, and varsity athletics in ALS

N Scarmeas et al.

NEUROLOGY (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.